Arrhythmogenic Inflammatory Cardiomyopathy: A Review
Brenton S Bauer1, Anthony Li1, Jason S Bradfield1
1UCLA Cardiac Arrhythmia Center, David Geffen School of Medicine at UCLA Los Angeles, USA.
Insights
Arrhythmogenic inflammatory cardiomyopathy involves heart inflammation causing ventricular arrhythmias. Early identification and targeted treatments, including immunosuppressants, are crucial for managing this condition.
Area of Science:
- Cardiology
- Electrophysiology
- Immunology
Background:
- Arrhythmogenic inflammatory cardiomyopathy is a distinct clinical entity within non-ischaemic cardiomyopathy.
- Patients present with ventricular arrhythmias and evidence of active cardiac inflammation.
- Understanding the underlying mechanisms (scar-mediated vs. direct inflammation) is vital for treatment selection.
Purpose of the Study:
- To define arrhythmogenic inflammatory cardiomyopathy.
- To outline diagnostic and therapeutic strategies for these patients.
- To highlight the importance of early identification and tailored management.
Main Methods:
- Clinical history and physical examination.
- Echocardiography.
- Advanced imaging: Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG PET-CT) and Cardiac Magnetic Resonance Imaging (CMR).
Main Results:
- Active cardiac inflammation is a key feature in this subgroup of cardiomyopathy patients.
- Combined medical therapy (neurohumeral agents and immunosuppressants) can improve ejection fraction and manage inflammation.
- Some patients may require invasive procedures like electrophysiologic study and radiofrequency catheter ablation.
Conclusions:
- Arrhythmogenic inflammatory cardiomyopathy requires a multi-faceted diagnostic and therapeutic approach.
- Early detection through advanced imaging is critical.
- Personalized treatment strategies, including immunosuppression and potentially ablation, improve outcomes.
Abstract:
Arrhythmogenic inflammatory cardiomyopathy is a recent clinical description of a subgroup of patients with non-ischaemic cardiomyopathy who are referred to electrophysiologists for evaluation and management of ventricular arrhythmias and are found to have evidence of active cardiac inflammation. The identification of these patients is key, since the aetiology of their arrhythmic burden is likely both related to scar-mediated and direct inflammatory mechanisms, which may have different treatment approaches. Evaluation of these patients starts with a full clinical history and physical examination along with echocardiography, as with most patients with cardiomyopathy, however, additional imaging with fluorodeoxyglucose PET-CT and cardiac MRI is crucial. Medical treatment is aimed at targeting traditional neurohumeral mediators to achieve recovery of ejection fraction, in addition to immunosuppressant medication to directly treat inflammation. While medical treatment alone is successful in many patients, some will require further invasive management with electrophysiologic study and radiofrequency catheter ablation.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Cardiomyopathy V: Interprofessional Care


